Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)
China flag China · Delayed Price · Currency is CNY
16.17
+0.15 (0.94%)
Oct 23, 2026, 3:04 PM CST

SHE:300119 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
3,4113,3983,0702,7092,0842,007
Revenue Growth
1.50%10.70%13.32%29.98%3.84%0.34%
Gross Profit
1,3591,3951,2501,1821,0101,038
Operating Income
365.94382.25375.04378.65350.43355.16
Net Income
348.1400.51300.72453.59346.7412.78
Earnings Per Share
0.770.880.650.980.751.03
EPS Growth
-11.10%34.93%-33.24%30.69%-27.00%2.02%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Pet Supply Chain
781.78633.43460.14--
Veterinary Biological Products
1,4751,3241,0731,0311,060
Pharmaceutical Preparations and Active Pharmaceutical Ingredients
1,0501,0401,1101,019921.45
Epidemic Control Services
69.9944.83---
Other
21.7828.2265.8634.4625.58
Total
3,3983,0702,7092,0842,007

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
1,5531,6941,9391,8211,9012,009
Total Debt
1,6161,4601,381897.03877.68738.99
Net Cash (Debt)
-63.19233.57557.7924.341,0241,270
Net Cash Growth
--58.12%-39.66%-9.70%-19.40%816.50%
Net Cash Per Share
-0.140.511.211.992.213.16

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
355.8297.53735.55410.13389.49382.63
Capital Expenditures
-184.08-176.1-185.34-251.66-372.43-305.88
Free Cash Flow
171.73121.43550.21158.4717.0576.75
Free Cash Flow Growth
-65.59%-77.93%247.21%829.28%-77.78%-40.63%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
39.84%41.04%40.71%43.65%48.44%51.71%
Operating Margin
10.73%11.25%12.22%13.98%16.81%17.70%
Pretax Margin
11.73%13.85%12.00%21.08%19.85%24.30%
Profit Margin
10.20%11.79%9.80%16.74%16.63%20.57%
FCF Margin
5.03%3.57%17.92%5.85%0.82%3.82%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.4000.4000.3000.4000.3000.350
Dividend Per Share Growth
33.33%33.33%-25.00%33.33%-14.29%-12.50%
Dividend Yield
2.47%2.13%1.61%2.44%1.61%1.45%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
21.0921.2828.1716.7024.9027.13
Forward PE
16.0616.5916.4914.6617.9519.57
P/FCF Ratio
42.7670.1915.4047.80506.25145.88
PS Ratio
2.152.512.762.804.145.58